Finally, several other antigens on glioblastoma are targeted in other trials, e.g., ephrin type-A receptor 2 (EphA2) (NCT02575261), GD2 (NCT03252171), and mucin 1 (MUC1) (NCT02839954, NCT02617134). Here, MUC1 is linked to glioblastoma.